Blank clinical risk-assessment clipboard on a stone garden bench with a small violet safety-check circle
bipolarsuicide-riskclinical-documentationrisk-assessment

Bipolar Suicide Rates: What to Cite in the Risk Note

Photo of Marcus Reilly
Marcus Reilly Practice Operations Editor 7 min read
Outline

Scroll the table sideways to view every column

Measure Figure Source and population What it changes in the note
Lifetime suicide attempts 33.9% (31.3 to 36.6%) Dong 2020; 79 epidemiological studies, 33,719 people Cite attempt burden, not death
Lifetime attempts, BD-I vs BD-II 36.3% vs 32.4%; not significant Novick 2010; 15 retrospective studies Do not treat BD-II as safer
Attempts in epidemiological samples 22.9% to 25.6% Schaffer 2015 ISBD Part I; post-2010 epi samples Name epi vs clinical sample
Suicide deaths, pooled incidence 164 per 100,000 person-years Schaffer 2015 ISBD Part I; n=172,852 Use incidence, not a lifetime percent
Death after first hospital contact About 8% men, 5% women, median 18 y Nordentoft 2011; Danish first-contact cohort Hospital-contact sample only
Suicide mortality vs general population SMR 17.1 (9.8 to 29.5) Chesney 2014 meta-review Relative SMR, not a percent who die

Scroll the table sideways to view every column

Measure Figure Source and population What it changes in the note
Current or recent depressive polarity OR 5.99 for attempts (wide CI) Schaffer 2015 correlates; 3 studies Name polarity today
First-episode polarity Depressive first episode associated with attempts Schaffer 2015 correlates meta-analysis Record first-episode polarity
Sex pattern Attempts higher in women; deaths 1.7:1 men Dong 2020; Schaffer 2015 Part I, 7 studies Split attempts from deaths
Course specifiers Higher lifetime attempts with BD-I, BD-NOS, rapid cycling Dong 2020 subgroup analyses Record specifier, not only BD
Comorbidity Anxiety, any SUD, alcohol, cluster B raise attempts Schaffer 2015 correlates meta-analysis Name comorbidity in the formulation
Death correlates Male sex; first-degree family suicide Schaffer 2015 correlates meta-analysis Family suicide history is a death line

You cite bipolar suicide rates so a later reader can see which figure you used and which sample it came from. A diagnosis of bipolar disorder is a chronic-risk marker. It is not a risk level, and it is not a substitute for the screen.

Educational reference for licensed mental health practitioners. It is not clinical, legal, or crisis advice, and it does not establish a standard of care. Requirements vary by state, payer, license, and setting.

Cite bipolar suicide rates by sample

Attempt rates and death rates are different measures. Mixing them is how a note turns a clinical sample into a prophecy.

Dong and colleagues pooled 79 observational studies (33,719 people) and reported a lifetime suicide-attempt prevalence of 33.9% (95% CI 31.3 to 36.6). Only epidemiological studies were included. That figure is a lifetime attempt history in those samples. It is not the chance this client will die. The same paper’s 1-year attempt prevalence (15.0%) rests on three studies, so keep it off the note unless you are citing those studies.

Epidemiological estimates still spread. The ISBD task force summarized large retrospective epidemiological studies published after 2010 at 22.9% to 25.6% lifetime attempts, with higher frequencies in clinical samples (STEP-BD 36%). If you write “about one in three,” say that you are citing the Dong 2020 epidemiological pool. If you write “about one in four,” say that you are citing the ISBD post-2010 epidemiological range. If you write 36 percent, name STEP-BD as a clinical sample.

Death is an incidence rate. The ISBD Part I pooled analysis (n = 172,852) reported 164 suicide deaths per 100,000 person-years (95% CI 5 to 324), or 0.164 per 100 person-years when weighted by exposure years. The same paper warned that published death rates may reflect higher-risk windows, so a simple lifetime percent is unreliable. Do not convert 164 per 100,000 person-years into “X percent will die.”

Relative risk is a third measure. Chesney, Goodwin, and Fazel’s meta-review reported a suicide SMR of 17.1 (95% CI 9.8 to 29.5) for bipolar disorder versus the general population. Write it as a standardized mortality ratio. Do not write it as a percent of your caseload.

Nordentoft, Mortensen, and Pedersen followed people after first hospital contact in Denmark. The ISBD papers report that cohort’s absolute suicide risk at about 8% for men and 5% for women over a median 18 years. That line belongs only when the client’s history includes hospital contact of that kind. It is not a community outpatient default.

Subtype does not lower attempt risk

Novick, Swartz, and Frank pooled retrospective reports and found lifetime attempts in 36.3% of bipolar I and 32.4% of bipolar II (OR 1.21, 95% CI 0.98 to 1.48, p = 0.07). The difference was not statistically significant. Dong’s subgroups associated higher lifetime attempts with bipolar I, bipolar NOS, and rapid cycling, and with female sex. Those are associations inside attempt data. They do not license a “bipolar II, therefore lower risk” sentence.

If the chart still says unspecified mood disorder, finish the family gate on the mood disorder ICD-10 page before you treat the suicide line as a bipolar-specific rate.

Phase and features that raise risk

Schaffer and the ISBD correlates paper found the strongest attempt association for depressive polarity of the current or most recent episode (OR 5.99, 95% CI 1.75 to 20.5), from three studies with a wide interval. Depressive polarity of the first episode also tracked with attempts. Mixed episodes were usually filed under mania in the source studies, so that paper did not produce a mixed-episode pooled OR. You still record mixed features when you see them. You do not invent a mixed-state rate.

Other attempt correlates in that meta-analysis: female sex, younger onset, comorbid anxiety, any substance use disorder, alcohol use disorder, illicit substance use, cluster B or borderline personality disorder, and first-degree family history of suicide. Suicide deaths associated with male sex and first-degree family history of suicide. Part I’s sex-specific death data (seven studies) sat at 1.7 men per 1 woman. Write attempts and deaths as separate lines. A woman with bipolar disorder is not “low death risk” because attempt rates run higher in women. A man is not “low attempt risk” because death ratios run the other way.

Polarity you cannot see in the room still belongs on a log. Assign the bipolar mood chart when you need a daily polarity, sleep, and activation record for the next visit. The chart does not diagnose bipolar disorder and does not replace the screen.

What the note records after a screen

After you screen, the note has to show the instrument, the responses, and the judgment. Bipolar suicide rates go in the formulation as context for chronic burden. They do not score the session.

Record, in this order:

  1. Instrument and key responses, in the client’s words where you can.
  2. Subtype and current polarity, including mixed features if present.
  3. Lifetime attempts and any suicide deaths in first-degree relatives.
  4. Static versus dynamic factors, plus protective factors.
  5. The risk judgment, with the rate you actually cited and the sample it came from.
  6. The action: safety steps, means counseling, contact plan, or a higher level of care.

For the screen loop itself, use the suicide risk assessment template. For the domains around that entry (self-harm, harm to others, neglect, functional collapse), use the mental health risk assessment guide. Cite the figures above in the formulation after the screen.

Review the risk note

Draft a fictional follow-up note, then review every risk detail before signing.

Draft a note
  • No credit card
Risk follow-up
Fictional · DAP note

Session detail

Sleep was shorter this week, so we reviewed the safety plan and next contact.

Draft for your review

DAP note is ready for clinician review and signature.

Confirm the documented follow-up →

References

  • Chesney, E., Goodwin, G. M., & Fazel, S. (2014). Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry, 13(2), 153–160. https://doi.org/10.1002/wps.20128
  • Dong, M., Lu, L., Zhang, L., Zhang, Q., Ungvari, G. S., Ng, C. H., Yuan, Z., Xiang, Y., Wang, G., & Xiang, Y.-T. (2020). Prevalence of suicide attempts in bipolar disorder: A systematic review and meta-analysis of observational studies. Epidemiology and Psychiatric Sciences, 29, e63. DOI
  • Nordentoft, M., Mortensen, P. B., & Pedersen, C. B. (2011). Absolute risk of suicide after first hospital contact in mental disorder. Archives of General Psychiatry, 68(10), 1058–1064. DOI
  • Novick, D. M., Swartz, H. A., & Frank, E. (2010). Suicide attempts in bipolar I and bipolar II disorder: A review and meta-analysis of the evidence. Bipolar Disorders, 12(1), 1–9. https://doi.org/10.1111/j.1399-5618.2009.00786.x
  • Schaffer, A., Isometsä, E. T., Tondo, L., Moreno, D. H., Sinyor, M., Kessing, L. V., Turecki, G., Weizman, A., Azorin, J.-M., Ha, K., Reis, C., Cassidy, F., Goldstein, T., Rihmer, Z., Beautrais, A., … Yatham, L. (2015). Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Australian and New Zealand Journal of Psychiatry, 49(9), 785–802. DOI
  • Schaffer, A., Isometsä, E. T., Tondo, L., Moreno, D., Turecki, G., Reis, C., Cassidy, F., Sinyor, M., Azorin, J.-M., Kessing, L. V., Ha, K., Goldstein, T., Weizman, A., Beautrais, A., Chou, Y.-H., Diazgranados, N., Levitt, A. J., Zarate, C. A., Jr., Rihmer, Z., & Yatham, L. N. (2015). International Society for Bipolar Disorders Task Force on Suicide: Meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disorders, 17(1), 1–16. DOI

Get the therapist toolkit

Practical, plainspoken notes on AI for therapy practices. No spam, unsubscribe any time.

By subscribing you agree to get the Emosapien therapist toolkit by email every two weeks. We never share your email. Unsubscribe any time.

Ready to transform your practice?

Join 10,000+ therapists using Emosapien.